Search

everythinglearnresearchcommunity

for

Search:↓

Patients prioritize quality of life, overall survival, and progression-free survival in treatment decisions for advanced breast cancer.

The treatment was effective and tolerable for advanced gastric cancer.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Certain hormone treatments can improve acne and related conditions in women.

Rubbing vitamin D3 on skin can help prevent hair loss from chemotherapy and slow breast tumor growth in mice.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

Abemaciclib can cause skin, hair, and nail problems, leading some patients to stop using it.

Skin side effects from melanoma immunotherapy are common and may indicate better survival.

Intralesional therapy for keratoacanthoma is effective and has fewer side effects than systemic treatments.

The combined treatment helped prevent hair loss and promoted full hair regrowth in breast cancer patients after chemotherapy.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

Erlotinib can cause acne-like skin issues, needing early treatment and possible dosage adjustments.

Childhood cancer survivors need better skin care and sun protection.

Antiandrogens can help treat skin conditions like acne and excessive hair in women when used carefully.

Chemotherapy can cause rapid, extensive hair loss, with patterns varying between individuals.

Birth control pills and cyproterone acetate can help treat acne in women, especially when linked to hormonal issues.

Adding cerium(III) chloride to Grignard reagents improves the making of compounds that could treat prostate issues and hair loss.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

Adapalene, Diosmin, and Azelastine could be repurposed to treat onchocerciasis.

A new platinum complex was made and studied, which might help fight cancer better.

Acitretin treats severe skin conditions but requires careful monitoring due to serious side effects.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

Suppressing eIF4E can prevent hair loss from chemotherapy.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.